
Help end
breast cancer.
Our mission is to save lives by meeting the most critical needs in our communities and investing in breakthrough research to prevent and cure breast cancer.
Support & Resources
You are not alone.
Our breast care helpline offers free support from trained oncology social workers, as well as guidance to local resources. Mon–Thur 9 a.m. to 7 p.m. ET and Fri 9 a.m. to 6 p.m. ET.
Se habla español.
We’re here for you.
Don’t let financial hardship keep you from getting the treatment you need. The Financial Assistance Program is here to help so you can focus on your care.
Breast Cancer Answers
Find the latest information on breast cancer risk factors, screening, diagnosis, treatment, metastatic breast cancer, survivorship and more.
Oral SERDs: Real-World Impact
See how oral selective estrogen receptor degraders (SERDs) are changing treatment for HR+ metastatic breast cancer, offering new options beyond traditional therapies.
Post-Surgical Recovery for Breast Cancer
Learn what to expect after breast cancer surgery—from healing and side effects to regaining strength and confidence.
A Guide to the 2026 American Society of Clinical Oncology Annual Meeting (ASCO)
Explore the biggest breast cancer research updates from ASCO 2026, including emerging treatments, clinical trials and future breakthroughs.


Start a Fundraiser or Join a Race or Walk.
Your support will help us fund life-saving research, treatment, education and community health programs.

The Impact
IN OUR MISSION TO END BREAST CANCER



People who have or have had breast cancer can help find the cures, faster.
Your breast cancer information is as unique as you are. When combined with other ShareForCures members, you provide scientists with a more diverse set of data to make new discoveries, faster.

The Latest from Komen
FROM THE BLOG AND REAL PINK
May 13, 2026

Gynna’s Story: Living with Metastatic Breast Cancer
Living with metastatic breast cancer, Gynna chooses hope, purpose and joy—showing that life can still be full after diagnosis.





